HY-111996

DB16964InvestigationalSmall molecule

HY-111996: Overview.

Mechanism: Pharmacologically active on Voltage-gated potassium channel KCNC1 and Voltage-gated potassium channel KCNC2
Curator reviewed
Also known as: 5,5-Dimethyl-3-(2-((7-methyl-2H-spiro[benzofuran-3,1'-cyclopropan]-4-yl)oxy)pyrimidin-5-yl)imidazolidine-2,4-dione · 5,5-dimethyl-3-[2-(7-methylspiro[2H-benzofuran-3,1'-cyclopropane]-4-yl)oxypyrimidin-5-yl]imidazolidine-2,4-dione
Code names: AUT-00206

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with HY-111996, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.